NIH Weekly Funding Opportunities and Policy Notices

Monday, February 12, 2018 - 8:57am
Notice NOT-HL-18-588 from the NIH Guide for Grants and Contracts
Monday, February 12, 2018 - 8:38am
Notice NOT-DA-17-067 from the NIH Guide for Grants and Contracts
Monday, February 12, 2018 - 7:01am
Funding Opportunity PA-18-651 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement encourages developmentally tailored research focused on adolescents and emerging adults as it relates to HIV prevention and treatment. Research is encouraged to incorporate recent advances in adolescent and young adult developmental research to optimize outcomes in HIV prevention and care research for this heterogeneous population. PA-FY-NNN uses the R01 grant mechanism, PA-FY-NNN uses the R21 mechanism, while PA-FY-NNN uses the R34 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. Applicants with preliminary data and/or planning to include longitudinal analysis may wish to apply using the R01 mechanism. Applicants wanting to develop and pilot test an intervention may wish to apply using the R34 mechanism.
Monday, February 12, 2018 - 7:01am
Funding Opportunity PA-18-652 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement encourages developmentally tailored research focused on adolescents and emerging adults as it relates to HIV prevention and treatment. Exploratory research is encouraged to incorporate recent advances in adolescent and young adult developmental research to better understand HIV prevention and care of this heterogeneous population. PA-FY-NNN uses the R01 grant mechanism, PA-FY-NNN uses the R21 mechanism, while PA-FY-NNN uses the R34 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. Applicants with preliminary data and/or planning to include longitudinal analysis may wish to apply using the R01 mechanism. Applicants wanting to develop and pilot test an intervention may wish to apply using the R34 mechanism
Monday, February 12, 2018 - 7:01am
Funding Opportunity PA-18-653 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement encourages developmentally tailored research focused on adolescents and emerging adults as it relates to HIV prevention and treatment. Research is encouraged to incorporate recent advances in adolescent and young adult developmental research to optimize outcomes in HIV prevention and care research for this heterogeneous population. PA-FY-NNN uses the R01 grant mechanism, PA-FY-NNN uses the R21 mechanism, while PA-FY-NNN uses the R34 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. Applicants with preliminary data and/or planning to include longitudinal analysis may wish to apply using the R01 mechanism. Applicants wanting to develop and pilot test an intervention may wish to apply using the R34 mechanism.
Friday, February 9, 2018 - 10:50am
Funding Opportunity PAR-18-649 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for research to examine 1) the impact of Human-Animal Interactions (HAI) on typical and atypical child development and health; 2) the evaluation of animal-assisted intervention for children and adults with disabilities or in need of rehabilitative services; 3) the effects of animals on public health, including cost effectiveness of involving animals in reducing and preventing disease.
Friday, February 9, 2018 - 10:50am
Funding Opportunity PAR-18-650 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for research to examine 1) the impact of Human-Animal Interactions (HAI) on typical and atypical child development and health; 2) the evaluation of animal-assisted intervention for children and adults with disabilities or in need of rehabilitative services; 3) the effects of animals on public health, including cost effectiveness of involving animals in reducing and preventing disease.
Friday, February 9, 2018 - 9:25am
Notice NOT-EB-18-006 from the NIH Guide for Grants and Contracts
Friday, February 9, 2018 - 9:25am
Funding Opportunity PA-18-648 from the NIH Guide for Grants and Contracts. The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
Thursday, February 8, 2018 - 11:11pm
Funding Opportunity RFA-NS-18-024 from the NIH Guide for Grants and Contracts. This FOA invites applications that will systematically and comprehensively characterize alpha-synuclein and amyloid-beta subspecies present in human Lewy Body Dementia (LBD) post-mortem brain tissue, identify toxic subspecies and potential mechanisms of toxicity, and characterize any interactions between the proteins that may contribute to increased toxicity and/or explain selective vulnerabilities of cells/circuits. Applications are required to include at least 3 hypothesis-driven projects that address these goals, an administrative core, and other cores as appropriate. Applicants will be expected to focus on the use of human tissues. All applications will be expected to include plans for developing a publicly-available library of fully characterized alpha-synuclein and amyloid-beta subspecies found in LBD.
Thursday, February 8, 2018 - 10:19am
Funding Opportunity PAR-18-643 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to accelerate the pace and expand the breadth of scientific research on the clinical course, prevention and treatment of diseases within NHLBI's mission by leveraging ongoing clinical research studies through ancillary studies. This FOA invites research project applications to conduct ancillary studies to clinical research studies, including clinical trials, prospective observational studies, and/or registries. Applications submitted to this FOA must propose to collect new information and/or biological samples from participants of the ongoing parent study, and must address new research questions that are beyond those specified in the approved protocol of the parent study and are within the scientific mission of the NHLBI. Applications submitted in response to this FOA cannot be used to extend the duration of the parent study or to provide funds solely for parent study enrollment, capitation, or study performance.
Thursday, February 8, 2018 - 10:15am
Funding Opportunity PAR-18-644 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Exploratory/Developmental Grants Phase II mechanism to provide support for expanded activities. Applicants are expected to have an existing research infrastructure developed either through PA-12-064, or with other NIH or non-NIH support. Through this award, investigators will develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Thursday, February 8, 2018 - 10:15am
Funding Opportunity PAR-18-645 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Thursday, February 8, 2018 - 9:42am
Notice NOT-TW-18-003 from the NIH Guide for Grants and Contracts
Thursday, February 8, 2018 - 9:01am
Funding Opportunity PA-18-647 from the NIH Guide for Grants and Contracts. NIAAA solicits administrative supplement applications to promote innovation and novel high-risk projects by early established investigators (EEIs). The supplement will allow EEIs to expand and explore new opportunities within the scope of the currently funded R01 grant, and to facilitate the transition from a single, structured research project to a research program.
Thursday, February 8, 2018 - 8:40am
Funding Opportunity RFA-AR-19-001 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.
Thursday, February 8, 2018 - 8:35am
Funding Opportunity RFA-AR-19-002 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for research areas within its mission in musculoskeletal biology and medicine. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on musculoskeletal biology and medicine, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Pages